Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine

ASIAIR > College of Computer Science > Department of Biomedical informatics > Journal Article > Item 310904400/81284

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/81284

Title:	Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
Authors:	陳語謙;Hsin-Chieh Tang
Contributors:	生物與醫學資訊學系
Date:	2014-06
Issue Date:	2014-10-08 05:57:40 (UTC+0)
Abstract:	One has found an important cell cycle controller. This guard can decide the cell cycle toward proliferation or quiescence. Cyclin-dependent kinase 2 (CDK2) is a unique target among the CDK family in melanoma therapy. We attempted to find out TCM compounds from TCM Database@Taiwan that have the ability to inhibit the activity of CDK2 by systems biology. We selected Tetrahydropalmatine, Reserpiline, and (+)-Corydaline as the candidates by docking and screening results for further survey. We utilized support vector machine (SVM), multiple linear regression (MLR) models and Bayesian network for validation of predicted activity. By overall analysis of docking results, predicted activity, and molecular dynamics (MD) simulation, we could conclude that Tetrahydropalmatine, Reserpiline, and (+)-Corydaline had better binding affinity than the control. All of them had the ability to inhibit the activity of CDK2 and might have the opportunity to be applied in melanoma therapy.
Relation:	JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY;2014:798742.
Appears in Collections:	[Department of Biomedical informatics ] Journal Article

Files in This Item:

File	Size	Format
index.html	0Kb	HTML	368	View/Open